ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 105 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,880,000 | -51.4% | 34,773 | +1.6% | 0.01% | -52.9% |
| Q4 2015 | $3,865,000 | -3.9% | 34,211 | +0.2% | 0.02% | -5.6% |
| Q3 2015 | $4,021,000 | +41.9% | 34,159 | -6.6% | 0.02% | +50.0% |
| Q2 2015 | $2,833,000 | +25.6% | 36,588 | -6.2% | 0.01% | +33.3% |
| Q1 2015 | $2,255,000 | +75.8% | 38,986 | -2.0% | 0.01% | +80.0% |
| Q4 2014 | $1,283,000 | +31.1% | 39,790 | -0.6% | 0.01% | +25.0% |
| Q3 2014 | $979,000 | +118.5% | 40,014 | +58.5% | 0.00% | +100.0% |
| Q2 2014 | $448,000 | +36.6% | 25,253 | +29.3% | 0.00% | +100.0% |
| Q4 2013 | $328,000 | +52.6% | 19,523 | -3.5% | 0.00% | 0.0% |
| Q3 2013 | $215,000 | +144.3% | 20,221 | +28.0% | 0.00% | – |
| Q2 2013 | $88,000 | – | 15,794 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 5,621,423 | $59,700,000 | 36.62% |
| VHCP Management, LLC | 1,610,856 | $17,107,000 | 9.45% |
| Broadfin Capital, LLC | 1,737,669 | $18,454,000 | 3.28% |
| Consonance Capital Management LP | 737,685 | $7,834,000 | 1.96% |
| Palo Alto Investors LP | 1,600,178 | $16,994,000 | 1.78% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 520,091 | $5,523,000 | 1.06% |
| QVT Financial LP | 1,358,303 | $14,425,000 | 0.98% |
| Lombard Odier Asset Management (USA) Corp | 1,700,000 | $18,054,000 | 0.91% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,702,300 | $18,061,000 | 0.89% |
| Perceptive Advisors | 1,947,736 | $20,684,000 | 0.85% |